Previous 10 | Next 10 |
Addex Therapeutics ( NASDAQ: ADXN ) and Indivior ( OTCPK:INVVY ) ( OTCPK:IZQVF ) extended the research term until June 30, 2023 of their collaboration to develop therapies for substance use disorder. The companies had signed an agreement to discover novel oral gamma-a...
Addex Therapeutics Ltd (ADXN) Q3 2022 Results Conference Call November 11, 2022 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and CEO Rob Lütjens - Head of Discovery, Biology Mikhail Kalinichev - Head of Translational Science C...
Addex Therapeutics press release ( NASDAQ: ADXN ): Q3 GAAP EPS of -CHF0.09. Income of CHF0.42M (-44.7% Y/Y). Cash and cash equivalents amounted to CHF 10.4M as of September 30, 2022 compared to CHF 15.5M as of September 30, 2021. The decrease of CHF 5.1M...
Addex Therapeutics ( NASDAQ: ADXN ) received a notice from Nasdaq for not being in compliance with the US$1 per ADS minimum bid price requirement for continued listing on the exchange. The company said it has 180 calendar days to regain compliance and will no...
Start Time: 10:00 End Time: 10:41 Addex Therapeutics Ltd (ADXN) Q2 2022 Earnings Conference Call August 18, 2022, 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and CEO Roger Mills - Chief Medical Officer Robert Lütjens - Head...
Addex Therapeutics press release ( NASDAQ: ADXN ): Q2 GAAP EPS of -CHF 0.19. Cash and cash equivalents amounted to CHF 8.8M as of June 30, 2022 compared to CHF 18.1M as of June 30, 2021. CHF 4.6M equity financing in July extends cash runway into Q2 2023. For...
Addex Therapeutics ( NASDAQ: ADXN ) and Indivior ( OTCPK:INVVY ) ( OTCPK:IZQVF ) extended their collaboration on discovering and developing novel oral gamma-aminobutyric acid subtype B (GABAB) positive allosteric modulator (PAM) drug candidates until March 31, 2023...
Gainers: Sunshine Biopharma ( SBFM ) +26% . InflaRx IFRX +14% . Talaris Therapeutics ( TALS ) +8% . Nutriband ( NTRB ) +7% . Biodesix ( BDSX ) +5% . Losers: Revelation Biosciences REVB -52% . Virax Biolabs VR...
McEwen Mining ( MUX ) -89% . Revelation Biosciences ( REVB ) -47% announces pricing of $5M public offering. The Aaron's ( AAN ) -22% on Q2 results. Koss ( KOSS ) -20% . Vinco Ventures ( BBIG ) -15% . ToughBuilt Indust...
Enveric Biosciences ( ENVB ) -20% announces $8M registered direct offering and private placement, priced at a premium to market under Nasdaq rules. Squarespace ( SQSP ) -13% on Q2 results. Baosheng Media Group Holdings ( BAOS ) -12% . Addex ...
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
Addex Therapeutics Ltd Website:
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...
Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that Mikhail Kalinichev, Head of T...